Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Kriya Therapeutics, Inc.

Kriya Therapeutics, Inc.

Stage unknownMorrisville, NCBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Jul 31, 2025
    Form D equity offering · $313M (form d sold) · 2 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Kriya Therapeutics, Inc. filed Form D: $313,297,440 sold of $313,297,440, Biotechnology”
Investors on record
1 edges
People
6 officers, 9 directors
Timeline
2
  1. Sep 10, 2025
    Kriya Therapeutics, Inc. filed Form D/A: $320,822,412 sold of $320,822,412, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Aug 15, 2025
    Kriya Therapeutics, Inc. filed Form D: $313,297,440 sold of $313,297,440, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this company